Blood test shows promise detecting 50+ cancer types early, including pancreatic

In Wisconsin, approximately 2 of 3 daily pancreatic cancer diagnoses result in death, highlighting the critical need for early detection methods.

Each day in Wisconsin, three people receive a pancreatic cancer diagnosis, and two of them will not survive it — a quiet tragedy that has persisted largely because the disease reveals itself only after it has already spread beyond reach. A health company called Grail has developed a blood test named Galleri that may begin to change this calculus, offering the possibility of detecting more than fifty cancer types in their earliest stages by reading the molecular signals cancer leaves in the bloodstream. The test is not yet approved by the FDA nor covered by insurance, but it stands at the thres

Blood test shows promise detecting 50+ cancer types early, including pancreatic

Cobertura Relacionada

Receba o Register no seu e-mail